Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer
Go back to Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 54.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.63 | 52 Week High | $35.13 | |||
| Open | $54.46 | 52 Week Low | $28.10 | |||
| Day High | $54.99 | P/E | N/A | |||
| Day Low | $54.43 | EPS | $0.00 | |||
| Volume | 1,225,786 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
| Roper Industries (NASDAQ: ROP) | Delayed: 374.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $374.76 | 52 Week High | $195.93 | |||
| Open | $374.93 | 52 Week Low | $155.79 | |||
| Day High | $377.21 | P/E | 69.79 | |||
| Day Low | $370.52 | EPS | $5.37 | |||
| Volume | 64 | |||||
